To determine the clinical utility of serum EphA2-NF for pancreatic cancer diagnosis, we first measured its concentration using CLIA in 299 serum samples in the test cohort (Fig. 2A; Supplementary Table S1). The gene discussed is NFASC; the disease is pancreatic neoplasm.